Recently, Lepu Medical has made new progress in many research products such as degradable stents and dual-chamber pacemakers, and the non-public issuance has been successfully approved. We have tracked the company's situation.
Analysis and judgment
Cardiovascular device upgrades, rapid development of other devices
Lepu Medical 's cardiovascular medical device product line has been gradually enriched and continuously upgraded. Recently, the double-chamber pacemaker has been approved in China, and the degradable stent has entered the special approval process. It is expected to be the first in China in the first half of 2018. In the future, the incidence of cardiovascular disease and interventional treatment rate in China will be clear. The upgrade of product lines through new products will increase the gross profit margin and achieve import substitution. It is expected to usher in a new round of leap-forward growth. At the same time, the company has achieved remarkable results through mergers and acquisitions to IVD, surgery and hemodialysis. It has achieved a comprehensive layout of the company in the field of medical devices, and is also in line with the correct path for medical device companies to grow and develop.
Pharmaceutical sales will maintain rapid growth in the future, and brand and consistency evaluation will strengthen competitive advantage
The company has heavy-duty varieties such as clopidogrel and atorvastatin. The current competitive pattern is good. Under the active promotion of winning the bid and sales, the growth rate in the first half of this year exceeded 100%. With its own brand accumulation in the cardiovascular field for many years, the company strives to first obtain a competitive advantage in pricing and bidding through consistency evaluation. The sales strategy is clear. First, we will open up grassroots hospitals and pharmacy channels, and gradually develop into the top three hospitals. The pharmaceutical business is expected to maintain a compound growth of more than 60% in the future and become the main driving force for the company's performance growth.
Flood Emergency Solution,Home Flood Protection,Freestanding Flood Barrier,Sewage Overflow Prevention
Denilco Environmental technology(Suzhou)Co., Ltd. , https://www.wflood.com